Adma Biologics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Adma Biologics
Tip: Access up to 7 years of quarterly data
All positions including Adma Biologics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Adma Biologics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19M | 1.3M | 14.66 |
| 2025-03-31 | $22M | 1.1M | 19.84 |
| 2024-12-31 | $2.3M | 136k | 17.15 |
| 2024-09-30 | $2.6M | 130k | 19.99 |
| 2024-06-30 | $1.5M | 130k | 11.18 |
| 2023-12-31 | $499k | 111k | 4.52 |
| 2023-09-30 | $396k | 111k | 3.58 |
| 2023-06-30 | $408k | 111k | 3.69 |
| 2023-03-31 | $366k | 111k | 3.31 |
| 2022-12-31 | $339k | 87k | 3.88 |
| 2022-09-30 | $239k | 98k | 2.43 |
| 2022-06-30 | $195k | 98k | 1.98 |
| 2020-03-31 | $106k | 37k | 2.88 |
| 2019-09-30 | $117k | 26k | 4.45 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors